Ben Sidders

R&D

Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.

News

Novartis has secured EU approval for Itvisma, a new formulation of its spinal muscular atrophy gene therapy usable in a broader patient population.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.